Clinical Trial Update: VEGA Prospective Kiel

View source ↗

Summary

The VEGA prospective Kiel clinical trial sponsored by Aesculap AG has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Snippet

Sponsor: Aesculap AG | Conditions: Degenerative Osteoarthritis, Rheumatoid Arthritis | Status: COMPLETED